ctrl K

Price Alert

Protara Therapeutics Inc. (TARA)

NASDAQ: TARA · Real-Time Price · USD

3.02

-0.17 (-5.33%)

At close: Aug 15, 2025, 3:08 PM

Protara Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	162.8M	39.59M	24.13M	35.72M
Short-Term Investments	7.49M	25.99M	60.24M	55.51M
Long-Term Investments	n/a	n/a	17.89M	39.47M
Other Long-Term Assets	772K	1.03M	1.3M	1.61M
Receivables	n/a	242K	486K	634K
Inventory	n/a	n/a	1.16M	n/a
Other Current Assets	2K	37K	-1.04M	34K
Total Current Assets	172.16M	68.7M	86.15M	93.11M
Property-Plant & Equipment	5.28M	6.56M	7.87M	8.89M
Goodwill & Intangibles	3.25M	2.66M	84K	29.52M
Total Long-Term Assets	9.3M	10.25M	27.14M	79.48M
Total Assets	181.45M	78.95M	113.29M	172.6M
Account Payables	4.43M	2.43M	1.59M	954K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	1.12M	n/a	n/a	855K
Other Current Liabilities	1.41M	2.11M	2.54M	946K
Total Current Liabilities	10.96M	6.15M	5.74M	4.3M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	3.36M	4.48M	5.47M	6.38M
Total Liabilities	14.32M	10.63M	11.21M	10.68M
Total Debt	4.48M	5.47M	6.38M	7.24M
Common Stock	35K	11K	11K	11K
Retained Earnings	-244.98M	-200.38M	-159.96M	-94.01M
Comprehensive Income	2K	-31K	-688K	-211K
Shareholders Equity	167.13M	68.32M	102.08M	161.91M
Total Investments	7.49M	25.99M	78.13M	94.97M